Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Published species reactivity||Human|
|Host / Isotype||Mouse / IgM|
|Immunogen||Lymphocytes/SU-DHL4 cell line.|
|Contains||0.05% sodium azide|
|Storage Conditions||Maintain refrigerated at 2-8°C for up to 1 month. For long term storage store at -20°C|
|Tested Applications||Dilution *|
|Immunohistochemistry (Paraffin, Frozen) (IHC (P, F))||1:5 - 1:10|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Immunohistochemistry (IHC)||See 2 publications below|
A suggested positive control for this product is human tonsil.
Natural killer (NK) cells in teleosts and their evolutionary homologue are a subpopulation of lymphocytes with properties that distinguish them from either B- or T-cells. NK cells are important effectors of innate immunity where they release cytokines, which in turn up-regulate other immunological functions. Monoclonal antibodies have been used to identify different surface antigens present on NK cells. These surface antigens have not only been used to identify NK cells, but also their functionally distinct subsets. The Cluster of Differentiation (CD) nomenclature was established to standardize the naming of NK cells.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Antibodies are forever: a study using 12-26-year-old expired antibodies.
MA1-35289 was used in immunohistochemistry to study the effective shelf-life of diagnostic antibodies
|Argentieri MC,Pilla D,Vanzati A,Lonardi S,Facchetti F,Doglioni C,Parravicini C,Cattoretti G||Histopathology (63:869)||2013|
Synthesis and expression of CDw75 antigen in human colorectal cancer.
MA1-35289 was used in immunohistochemistry to study the expression of the CDw75 antigen in human colorectal cancer
|Costa-Nogueira C,Villar-Portela S,Cuevas E,Gil-Martín E,Fernández-Briera A||BMC cancer (9:null)||2010|
6-sialyltransferase; 6-sialyltransferase 1; 6-ST 1; alpha 2; alpha 2,6-ST 1; B-cell antigen CD75; beta-galactoside alpha-2; CMP-N-acetylneuraminate beta-galactosamide alpha-2; CMP-N-acetylneuraminate beta-galactosamide alpha-2,6-sialyltransferase; CMP-N-acetylneuraminate-beta-galactosamide-alpha-2; CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase 1; sialyltransferase 1; sialyltransferase 1 (beta-galactoside alpha-2,6-sialyltransferase); SIAT1; ST6 beta-galactosamide alpha-2,6-sialyltranferase 1; ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1; ST6Gal I; ST6GalI; ST6N
SIAT1; ST6GAL1; ST6GalI; ST6N